Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - large image1
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - image1
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - image2
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - image3
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - image4
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - image5
Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material buy - image6

Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material

TDS 7503 Inquiries

Unit Price:

$75.6-81/MT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

ZHOUSHAN

Brand:

TP002

Packaging:

5mg/10mg/15mg/20mg/30mg per glass vial, neutral export packing

Price valid (until):

2026-11-26

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/A,100% TT in advance
Average Lead Time:
15 days
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,GHK-CU

  • Product Details

  • Seller Information

  • History Price

  • Inquiry History

  • Description


      Product Detail  


    Disclaimer: Intended solely for research applications. Not for human or veterinary administration.

    Product Overview

    Retatrutide, also designated LY3437943, is a cutting‑edge synthetic triple‑receptor agonist that selectively targets GLP‑1R, GIPR and GCGR. Widely adopted within academic and lab‑based research, this peptide facilitates experimental work focused on metabolic regulation, glucose homeostasis assessment and pharmacological mechanism investigation. Supplied as high‑purity white lyophilized powder, it delivers dependable batch‑to‑batch uniformity. Manufactured in‑house under standardized protocols and kept in ample stock, it caters to medium‑to‑large recurring procurement demands from research labs and institutes worldwide.
    Brief Introduction:Our factory‑sourced Retatrutide (LY3437943) lyophilized peptide powder delivers HPLC‑confirmed purity ≥99%. Multiple vial sizes are on offer. It maintains consistent batch performance, comes with full‑set analytical documentation and is readily available from stock. Exclusively for lab‑only research, this peptide serves studies on metabolism, glucose modulation and pharmacodynamic mechanisms, delivering reproducible, reliable experimental outputs for global research projects.

    Research‑Oriented Use Cases

    This peptide is restricted strictly to laboratory‑based research. Eligible applications cover in‑vitro studies on triple‑receptor activation, metabolic and glycometabolism experimental modeling, pharmacological comparison assays, peptide activity evaluation, academic research projects and lab‑scale sample development.

    Key Product Strengths

    Superior Purity & Stable Chemical Properties

    Manufactured against rigorous HPLC benchmarks, the product reaches ≥99% purity with minimal impurity levels. Its chemical profile remains stable; degradation risk stays low under standard lab handling and recommended storage conditions.

    Trustworthy Bio‑Activity

    Fine‑tuned synthetic peptide structure guarantees steady, verifiable biological activity, supporting consistent, replicable test results for pharmacology‑ and metabolism‑focused research programs.

    Full Batch‑Specific Analytical Documentation

    Every production lot undergoes complete analytical testing. Supporting files including COA, HPLC chromatograms and MS spectra can be furnished, enabling full traceability and qualification validation.

    Flexible Size Selection

    Standard vial formats include 5 mg, 10 mg, 15 mg, 20 mg and 30 mg, suiting diverse experimental dosage requirements and research cycle lengths.

    Advanced Lyophilization Workflow

    Vacuum freeze‑drying manufacturing preserves native peptide bio‑activity, prevents activity loss associated with conventional drying workflows and extends usable shelf life.

    Rigorous Quality Management

    Production follows standardized in‑factory workflows, strict raw‑material screening and fixed synthesis protocols. Lot‑to‑lot consistency is guaranteed, eliminating cross‑batch mixing or quality variance.

    Core Product Specifications

    Official product name: Retatrutide;code name: LY3437943;CAS No.:2381089‑83‑2. Molecular formula: C₂₂₁H₃₄₂N₄₆O₆₈;molecular weight:4731.33. Physical appearance: white to off‑white lyophilized powder; HPLC purity ≥99%. It can be reconstituted with sterile water or PBS buffer for lab‑related preparation.
    Storage guidelines: Seal dry lyophilized powder and store in dry, dark surroundings at ‑20 ℃; shelf life reaches 3 years. Once reconstituted, seal the solution and store at ‑20 ℃. Avoid repeated freeze‑thaw cycles to preserve biological potency. Cold‑chain ice‑pack logistics are applied throughout transit to safeguard product stability.

    Quality Control Criteria

    Visually, the material presents as homogeneous white lyophilized cake or powder, free of visible foreign particles and color deviation. HPLC purity is maintained ≥99%, single impurity ≤0.5%, total impurity ≤1.0%. Loss‑on‑drying testing controls moisture content ≤5.0%.
    Mass‑spectrometry characterization verifies measured molecular weight matches theoretical values, confirming correct peptide structure. Stable raw‑material sources and fixed synthesis workflows secure consistent qualified test outcomes lot‑by‑lot. Batch‑specific certification files are available for customer quality validation and experimental filing purposes.

    Detail‑Page Visual Recommendations

    • Vial close‑up: High‑resolution shot of lyophilized powder inside individual vials, showcasing fine, non‑agglomerated texture to reflect high‑grade quality and precise manufacturing.
    • Multi‑size showcase: Neat arrangement of 5 mg,10 mg,20 mg,30 mg vials for intuitive size reference to help researchers pick matching experimental dosages.
    • Packaging visuals: Display sterile glass vials with vacuum‑lyophilized sealing. Highlight independent sealed dust‑proof, moisture‑proof units plus export‑grade outer cartons for secure cross‑border shipment.
    • Lab‑scene imagery: Present typical lab workflows such as pipetting, solution preparation and experimental assays, emphasizing its research‑only positioning.
    • Test‑document preview: Visual sample snippets of COA, HPLC and MS reports to demonstrate complete quality‑control workflows.
    • Warehouse & packing footage: Show standardized warehouse stock and cold‑packing operations, illustrating sufficient spot supply and reliable worldwide export capacity.

    Our Competitive Advantages

    We operate as direct‑source manufacturer with ample ready‑to‑ship inventory and reliable worldwide delivery. Each shipment comes with complete batch‑specific test reports for customer verification. Pre‑shipment inspections secure sustained high purity and cross‑batch consistency. Neutral non‑identifiable packaging can be arranged to safeguard purchasing confidentiality. Our specialized technical‑support team offers long‑term consultation and product‑related assistance.

    Order & Cooperation Notes

    Custom sizes, small trial lots and large‑volume long‑term lab‑oriented procurement are all accepted. Please connect with our specialist sales team for real‑time stock updates, batch documents and wholesale quotations. We deliver comprehensive, efficient and reliable peptide raw‑material supply solutions for global research institutes.

    Full Disclaimer

    This product is for laboratory scientific research only. It shall not be administered to humans or animals, used for clinical treatment, injection or any medical‑related commercial purposes. All goods comply with international standards for laboratory materials. Buyers and end‑users shall take full responsibility for complying with applicable local laws and industry compliance rules.
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 1
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 2
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 3
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 4
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 5
    Disclaimer: Intended solely for research applications. Not for human or veterinary administration.

    Product Overview

    Retatrutide, also designated LY3437943, is a cutting‑edge synthetic triple‑receptor agonist that selectively targets GLP‑1R, GIPR and GCGR. Widely adopted within academic and lab‑based research, this peptide facilitates experimental work focused on metabolic regulation, glucose homeostasis assessment and pharmacological mechanism investigation. Supplied as high‑purity white lyophilized powder, it delivers dependable batch‑to‑batch uniformity. Manufactured in‑house under standardized protocols and kept in ample stock, it caters to medium‑to‑large recurring procurement demands from research labs and institutes worldwide.
    Brief Introduction:Our factory‑sourced Retatrutide (LY3437943) lyophilized peptide powder delivers HPLC‑confirmed purity ≥99%. Multiple vial sizes are on offer. It maintains consistent batch performance, comes with full‑set analytical documentation and is readily available from stock. Exclusively for lab‑only research, this peptide serves studies on metabolism, glucose modulation and pharmacodynamic mechanisms, delivering reproducible, reliable experimental outputs for global research projects.

    Research‑Oriented Use Cases

    This peptide is restricted strictly to laboratory‑based research. Eligible applications cover in‑vitro studies on triple‑receptor activation, metabolic and glycometabolism experimental modeling, pharmacological comparison assays, peptide activity evaluation, academic research projects and lab‑scale sample development.

    Key Product Strengths

    Superior Purity & Stable Chemical Properties

    Manufactured against rigorous HPLC benchmarks, the product reaches ≥99% purity with minimal impurity levels. Its chemical profile remains stable; degradation risk stays low under standard lab handling and recommended storage conditions.

    Trustworthy Bio‑Activity

    Fine‑tuned synthetic peptide structure guarantees steady, verifiable biological activity, supporting consistent, replicable test results for pharmacology‑ and metabolism‑focused research programs.

    Full Batch‑Specific Analytical Documentation

    Every production lot undergoes complete analytical testing. Supporting files including COA, HPLC chromatograms and MS spectra can be furnished, enabling full traceability and qualification validation.

    Flexible Size Selection

    Standard vial formats include 5 mg, 10 mg, 15 mg, 20 mg and 30 mg, suiting diverse experimental dosage requirements and research cycle lengths.

    Advanced Lyophilization Workflow

    Vacuum freeze‑drying manufacturing preserves native peptide bio‑activity, prevents activity loss associated with conventional drying workflows and extends usable shelf life.

    Rigorous Quality Management

    Production follows standardized in‑factory workflows, strict raw‑material screening and fixed synthesis protocols. Lot‑to‑lot consistency is guaranteed, eliminating cross‑batch mixing or quality variance.

    Core Product Specifications

    Official product name: Retatrutide;code name: LY3437943;CAS No.:2381089‑83‑2. Molecular formula: C₂₂₁H₃₄₂N₄₆O₆₈;molecular weight:4731.33. Physical appearance: white to off‑white lyophilized powder; HPLC purity ≥99%. It can be reconstituted with sterile water or PBS buffer for lab‑related preparation.
    Storage guidelines: Seal dry lyophilized powder and store in dry, dark surroundings at ‑20 ℃; shelf life reaches 3 years. Once reconstituted, seal the solution and store at ‑20 ℃. Avoid repeated freeze‑thaw cycles to preserve biological potency. Cold‑chain ice‑pack logistics are applied throughout transit to safeguard product stability.

    Quality Control Criteria

    Visually, the material presents as homogeneous white lyophilized cake or powder, free of visible foreign particles and color deviation. HPLC purity is maintained ≥99%, single impurity ≤0.5%, total impurity ≤1.0%. Loss‑on‑drying testing controls moisture content ≤5.0%.
    Mass‑spectrometry characterization verifies measured molecular weight matches theoretical values, confirming correct peptide structure. Stable raw‑material sources and fixed synthesis workflows secure consistent qualified test outcomes lot‑by‑lot. Batch‑specific certification files are available for customer quality validation and experimental filing purposes.

    Detail‑Page Visual Recommendations

    • Vial close‑up: High‑resolution shot of lyophilized powder inside individual vials, showcasing fine, non‑agglomerated texture to reflect high‑grade quality and precise manufacturing.
    • Multi‑size showcase: Neat arrangement of 5 mg,10 mg,20 mg,30 mg vials for intuitive size reference to help researchers pick matching experimental dosages.
    • Packaging visuals: Display sterile glass vials with vacuum‑lyophilized sealing. Highlight independent sealed dust‑proof, moisture‑proof units plus export‑grade outer cartons for secure cross‑border shipment.
    • Lab‑scene imagery: Present typical lab workflows such as pipetting, solution preparation and experimental assays, emphasizing its research‑only positioning.
    • Test‑document preview: Visual sample snippets of COA, HPLC and MS reports to demonstrate complete quality‑control workflows.
    • Warehouse & packing footage: Show standardized warehouse stock and cold‑packing operations, illustrating sufficient spot supply and reliable worldwide export capacity.

    Our Competitive Advantages

    We operate as direct‑source manufacturer with ample ready‑to‑ship inventory and reliable worldwide delivery. Each shipment comes with complete batch‑specific test reports for customer verification. Pre‑shipment inspections secure sustained high purity and cross‑batch consistency. Neutral non‑identifiable packaging can be arranged to safeguard purchasing confidentiality. Our specialized technical‑support team offers long‑term consultation and product‑related assistance.

    Order & Cooperation Notes

    Custom sizes, small trial lots and large‑volume long‑term lab‑oriented procurement are all accepted. Please connect with our specialist sales team for real‑time stock updates, batch documents and wholesale quotations. We deliver comprehensive, efficient and reliable peptide raw‑material supply solutions for global research institutes.

    Full Disclaimer

    This product is for laboratory scientific research only. It shall not be administered to humans or animals, used for clinical treatment, injection or any medical‑related commercial purposes. All goods comply with international standards for laboratory materials. Buyers and end‑users shall take full responsibility for complying with applicable local laws and industry compliance rules.
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 6
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 7
    Shop High Purity Retatrutide LY3437943 Peptide 5mg 10mg Vial Research Use Only-Detailed Image 8
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • Retatrutide Raw Powder High Purity Pharmaceutical Grade Peptide Material Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,GHK-CU

    Location:

    Room 1209, 12th Floor, Unit 1, Building 1, Block A, Shenglong Plaza, No.80 Weiyang Road, Weiyang District, Xi'an City, Shaanxi Province, P.R.China

    Payment Terms:

    TT against copy of documents,D/A,100% TT in advance

    Average lead Time:

    15 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

    Xi'an Haoming Technology Co., Ltd. Founded in 2020, we are a professional supplier of high‑quality functional peptides. Our main product range includes weight‑loss peptides, anti‑wrinkle peptides, tanning peptides and other active peptide ingredients, widely used in cosmetics, skincare and health‑care industries. Strict quality‑control standards are applied throughout raw‑material screening, production and shipment to deliver consistent and reliable product quality.

    Putting customer value first, we supply premium‑grade products with competitive pricing, flexible MOQs and on‑time delivery. Our goods are well‑sold across Europe, the UK, the USA, Canada, Australia and other regions, earning wide recognition and trust from global buyers.

    We maintain stable independent international logistics channels covering the USA, Canada, UK, Germany, Spain, Poland, the Netherlands, Russia, Kazakhstan and more. One‑stop door‑to‑door delivery with full customs‑clearance service is available to free customers from cross‑border logistics troubles.

    Upholding the business philosophy of “Survive by Quality, Develop by Reputation”, Xi'an Haoming Technology Co., Ltd. keeps tight control over raw‑material procurement and production procedures. Free samples are offered prior to formal orders. All items are manufactured efficiently under high‑safety standards. Backed by a complete after‑sales system, we deliver prompt replies and professional solutions for satisfying cooperation.

    With consistent integrity, professional technical support and efficient service, we keep providing overseas partners with stable quality, competitive rates and reliable after‑sales support. Xi'an Haoming Technology Co., Ltd. aims to be your trusted long‑term supplier for peptide raw materials.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    7503 Inquiries
    Country Product Purchase Quantity Date Posted
    Malaysia

    Retatrutide

    20 MG Oct 28, 2026
    Australia

    Retaturtide

    100 MG Oct 29, 2026
    United States

    Retatrutide 30mg and 50mg

    20 PCS Oct 29, 2026
    Belgium

    Retatrutide

    1 MG Oct 29, 2026
    Romania

    Retatrutide

    10 G Oct 29, 2026
    United States

    Retatrutide

    2 MT Oct 29, 2026
    United States

    Retatrutide

    1 MT Oct 29, 2026
    United Kingdom

    Retatrutide

    1 PCS Oct 28, 2026
    United States

    Retatrutide

    30 MT Oct 28, 2026
    United Kingdom

    Retatrutide

    10 MT Oct 28, 2026
    United States

    retatrutide

    30 MG Oct 28, 2026
    Czech

    Retatrutide

    10 MG Oct 28, 2026
    Austria

    retatrutide

    30 MG Oct 28, 2026
    United States

    Retatrutide

    100 KG Oct 28, 2026
    Malta

    Retatrutide

    10 MT Oct 28, 2026
    United States

    Retatrutide

    600 MG Oct 28, 2026
    United States

    Retatrutide

    500 G Oct 28, 2026
    United States

    Retatrutide

    60 G Oct 28, 2026
    Croatia

    Retatrutide

    10 MG Oct 28, 2026
    United States

    Retatrutide

    200 MG Oct 28, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.